Page last updated: 2024-08-21

dronabinol and Melanoma

dronabinol has been researched along with Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, JL; Babatunde, F; Corazzari, M; Eleni Anagnostou, M; Hernandez-Tiedra, S; Hill, DS; Lopez-Valero, I; Lorente, M; Lovat, PE; McKee, CS; Redfern, CPF; Velasco, G1
Bald, T; Gaffal, E; Glodde, N; Jakobs, M; Tüting, T1
Emmert, S; Hänssle, H; Kretschmer, L; Neumann, C; Zutt, M1

Other Studies

3 other study(ies) available for dronabinol and Melanoma

ArticleYear
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
    The Journal of investigative dermatology, 2015, Volume: 135, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cannabidiol; Cannabinoids; Cannabinol; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dronabinol; Drug Combinations; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plant Extracts; Proto-Oncogene Proteins B-raf; ras Proteins; Skin Neoplasms; Temozolomide

2015
Differential role of cannabinoids in the pathogenesis of skin cancer.
    Life sciences, 2015, Oct-01, Volume: 138

    Topics: Animals; Cannabinoids; Cell Line, Tumor; Dronabinol; Fibrosarcoma; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Transplantation; Papilloma; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Skin Neoplasms

2015
[Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2006, Volume: 57, Issue:5

    Topics: Adult; Aged; Analgesics, Non-Narcotic; Chemotherapy, Adjuvant; Dronabinol; Feeding and Eating Disorders; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nausea; Palliative Care; Quality of Life; Skin Neoplasms; Treatment Outcome

2006